Our name, Imago, (pron. i-mắ-go), invokes the final and fully developed stage of an insect after its metamorphosis. In this process of growth and development, the imago refers to the fully formed adult, one that has completed its transformation and, for a butterfly, has taken flight. In our view, the full maturation of a scientific idea or observation in medical research is when new treatments prove their worth in clinical studies. To patients, anything less is to miss the mark.
Imago is developing pioneering medicines for the treatment of myeloproliferative diseases.
Meet Our TeamImago BioSciences is a clinical-stage, private therapeutics company focused on malignant and life-threatening diseases of the bone marrow.
Investors